nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP2A6—Methoxsalen—hematologic cancer	0.0315	0.0359	CbGbCtD
Cisapride—CYP1A2—Anagrelide—hematologic cancer	0.0269	0.0306	CbGbCtD
Cisapride—CYP2B6—Thiotepa—hematologic cancer	0.0264	0.03	CbGbCtD
Cisapride—CYP2A6—Ifosfamide—hematologic cancer	0.023	0.0262	CbGbCtD
Cisapride—CYP2C9—Bexarotene—hematologic cancer	0.0168	0.0191	CbGbCtD
Cisapride—CYP3A7—Ifosfamide—hematologic cancer	0.0157	0.0179	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0157	0.0179	CbGbCtD
Cisapride—CYP2A6—Prednisolone—hematologic cancer	0.0153	0.0174	CbGbCtD
Cisapride—CYP3A7—Imatinib—hematologic cancer	0.015	0.0171	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.015	0.0171	CbGbCtD
Cisapride—CYP2B6—Ifosfamide—hematologic cancer	0.015	0.017	CbGbCtD
Cisapride—CYP2C8—Bortezomib—hematologic cancer	0.0148	0.0168	CbGbCtD
Cisapride—CYP3A5—Daunorubicin—hematologic cancer	0.0147	0.0167	CbGbCtD
Cisapride—CYP2D6—Lomustine—hematologic cancer	0.0143	0.0163	CbGbCtD
Cisapride—CYP1A2—Carmustine—hematologic cancer	0.0141	0.0161	CbGbCtD
Cisapride—CYP2C9—Idarubicin—hematologic cancer	0.0139	0.0159	CbGbCtD
Cisapride—CYP3A5—Thalidomide—hematologic cancer	0.0134	0.0152	CbGbCtD
Cisapride—CYP2B6—Nilotinib—hematologic cancer	0.013	0.0148	CbGbCtD
Cisapride—CYP3A5—Teniposide—hematologic cancer	0.0128	0.0145	CbGbCtD
Cisapride—CYP2D6—Idarubicin—hematologic cancer	0.0127	0.0145	CbGbCtD
Cisapride—CYP2C19—Bortezomib—hematologic cancer	0.0124	0.0141	CbGbCtD
Cisapride—CYP1A2—Methoxsalen—hematologic cancer	0.012	0.0137	CbGbCtD
Cisapride—CYP3A5—Ifosfamide—hematologic cancer	0.0118	0.0134	CbGbCtD
Cisapride—CYP1A2—Bortezomib—hematologic cancer	0.0114	0.013	CbGbCtD
Cisapride—CYP2C8—Ifosfamide—hematologic cancer	0.0113	0.0129	CbGbCtD
Cisapride—CYP3A5—Imatinib—hematologic cancer	0.0113	0.0128	CbGbCtD
Cisapride—CYP1A2—Daunorubicin—hematologic cancer	0.0109	0.0125	CbGbCtD
Cisapride—CYP2D6—Hydroxyurea—hematologic cancer	0.0108	0.0123	CbGbCtD
Cisapride—CYP2C19—Thalidomide—hematologic cancer	0.0108	0.0123	CbGbCtD
Cisapride—CYP1A2—Alitretinoin—hematologic cancer	0.0107	0.0122	CbGbCtD
Cisapride—CYP2C9—Bortezomib—hematologic cancer	0.0103	0.0117	CbGbCtD
Cisapride—CYP2C19—Teniposide—hematologic cancer	0.0103	0.0117	CbGbCtD
Cisapride—CYP1A2—Thalidomide—hematologic cancer	0.00996	0.0113	CbGbCtD
Cisapride—CYP2C8—Nilotinib—hematologic cancer	0.00983	0.0112	CbGbCtD
Cisapride—CYP3A4—Bexarotene—hematologic cancer	0.00977	0.0111	CbGbCtD
Cisapride—CYP2C19—Ifosfamide—hematologic cancer	0.0095	0.0108	CbGbCtD
Cisapride—CYP2D6—Bortezomib—hematologic cancer	0.00942	0.0107	CbGbCtD
Cisapride—CYP3A7—Irinotecan—hematologic cancer	0.00937	0.0107	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00937	0.0107	CbGbCtD
Cisapride—CYP3A4—Lomustine—hematologic cancer	0.00909	0.0103	CbGbCtD
Cisapride—CYP3A4—Busulfan—hematologic cancer	0.00909	0.0103	CbGbCtD
Cisapride—CYP2C19—Imatinib—hematologic cancer	0.00908	0.0103	CbGbCtD
Cisapride—CYP3A5—Dasatinib—hematologic cancer	0.00904	0.0103	CbGbCtD
Cisapride—CYP2A6—Dexamethasone—hematologic cancer	0.00903	0.0103	CbGbCtD
Cisapride—CYP2C9—Thalidomide—hematologic cancer	0.00897	0.0102	CbGbCtD
Cisapride—CYP2B6—Irinotecan—hematologic cancer	0.00892	0.0102	CbGbCtD
Cisapride—CYP1A2—Dacarbazine—hematologic cancer	0.00856	0.00975	CbGbCtD
Cisapride—CYP2C9—Teniposide—hematologic cancer	0.00856	0.00975	CbGbCtD
Cisapride—CYP1A2—Imatinib—hematologic cancer	0.00838	0.00954	CbGbCtD
Cisapride—CYP3A7—Vincristine—hematologic cancer	0.00819	0.00933	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00819	0.00933	CbGbCtD
Cisapride—CYP3A4—Thiotepa—hematologic cancer	0.0081	0.00922	CbGbCtD
Cisapride—CYP2C9—Ifosfamide—hematologic cancer	0.0079	0.009	CbGbCtD
Cisapride—CYP2C9—Imatinib—hematologic cancer	0.00755	0.0086	CbGbCtD
Cisapride—CYP2B6—Cisplatin—hematologic cancer	0.00727	0.00828	CbGbCtD
Cisapride—CYP3A5—Irinotecan—hematologic cancer	0.00703	0.00801	CbGbCtD
Cisapride—CYP2D6—Imatinib—hematologic cancer	0.0069	0.00786	CbGbCtD
Cisapride—CYP2C9—Nilotinib—hematologic cancer	0.00686	0.00781	CbGbCtD
Cisapride—CYP1A2—Dasatinib—hematologic cancer	0.00673	0.00766	CbGbCtD
Cisapride—CYP3A4—Methoxsalen—hematologic cancer	0.0063	0.00717	CbGbCtD
Cisapride—CYP2D6—Nilotinib—hematologic cancer	0.00627	0.00714	CbGbCtD
Cisapride—CYP2D6—Vinorelbine—hematologic cancer	0.00622	0.00708	CbGbCtD
Cisapride—CYP3A7—Dexamethasone—hematologic cancer	0.00617	0.00703	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00617	0.00703	CbGbCtD
Cisapride—CYP3A5—Vincristine—hematologic cancer	0.00614	0.007	CbGbCtD
Cisapride—CYP3A4—Bortezomib—hematologic cancer	0.00599	0.00682	CbGbCtD
Cisapride—CYP2C19—Prednisone—hematologic cancer	0.00598	0.00681	CbGbCtD
Cisapride—CYP2B6—Dexamethasone—hematologic cancer	0.00588	0.00669	CbGbCtD
Cisapride—CYP3A4—Daunorubicin—hematologic cancer	0.00573	0.00652	CbGbCtD
Cisapride—CYP3A5—Etoposide—hematologic cancer	0.00563	0.00641	CbGbCtD
Cisapride—CYP2C8—Etoposide—hematologic cancer	0.00541	0.00617	CbGbCtD
Cisapride—CYP3A4—Cytarabine—hematologic cancer	0.00505	0.00576	CbGbCtD
Cisapride—CYP3A4—Teniposide—hematologic cancer	0.00498	0.00567	CbGbCtD
Cisapride—CYP2B6—Doxorubicin—hematologic cancer	0.00487	0.00555	CbGbCtD
Cisapride—CYP3A5—Dexamethasone—hematologic cancer	0.00463	0.00527	CbGbCtD
Cisapride—CYP3A4—Ifosfamide—hematologic cancer	0.00459	0.00523	CbGbCtD
Cisapride—CYP2C8—Dexamethasone—hematologic cancer	0.00445	0.00507	CbGbCtD
Cisapride—CYP3A4—Imatinib—hematologic cancer	0.00439	0.005	CbGbCtD
Cisapride—CYP1A2—Etoposide—hematologic cancer	0.00419	0.00477	CbGbCtD
Cisapride—CYP3A4—Ruxolitinib—hematologic cancer	0.00413	0.00471	CbGbCtD
Cisapride—CYP3A4—Nilotinib—hematologic cancer	0.00399	0.00454	CbGbCtD
Cisapride—CYP3A4—Vinorelbine—hematologic cancer	0.00395	0.0045	CbGbCtD
Cisapride—CYP2C9—Cisplatin—hematologic cancer	0.00384	0.00438	CbGbCtD
Cisapride—CYP2D6—Vinblastine—hematologic cancer	0.00383	0.00436	CbGbCtD
Cisapride—CYP2C19—Dexamethasone—hematologic cancer	0.00373	0.00425	CbGbCtD
Cisapride—CYP3A4—Triamcinolone—hematologic cancer	0.00362	0.00412	CbGbCtD
Cisapride—CYP3A4—Dasatinib—hematologic cancer	0.00352	0.00401	CbGbCtD
Cisapride—CYP3A4—Mitoxantrone—hematologic cancer	0.00348	0.00396	CbGbCtD
Cisapride—CYP2C9—Dexamethasone—hematologic cancer	0.0031	0.00354	CbGbCtD
Cisapride—CYP3A4—Betamethasone—hematologic cancer	0.0031	0.00353	CbGbCtD
Cisapride—CYP3A4—Prednisolone—hematologic cancer	0.00306	0.00349	CbGbCtD
Cisapride—CYP3A4—Prednisone—hematologic cancer	0.00289	0.00329	CbGbCtD
Cisapride—CYP2D6—Dexamethasone—hematologic cancer	0.00284	0.00323	CbGbCtD
Cisapride—CYP3A4—Irinotecan—hematologic cancer	0.00274	0.00312	CbGbCtD
Cisapride—CYP3A4—Vinblastine—hematologic cancer	0.00244	0.00278	CbGbCtD
Cisapride—CYP3A4—Vincristine—hematologic cancer	0.0024	0.00273	CbGbCtD
Cisapride—CYP2D6—Doxorubicin—hematologic cancer	0.00235	0.00268	CbGbCtD
Cisapride—CYP3A4—Etoposide—hematologic cancer	0.0022	0.0025	CbGbCtD
Cisapride—CYP3A4—Dexamethasone—hematologic cancer	0.00181	0.00206	CbGbCtD
Cisapride—CYP3A4—Doxorubicin—hematologic cancer	0.0015	0.00171	CbGbCtD
Cisapride—HTR3A—hematopoietic system—hematologic cancer	0.00113	0.0599	CbGeAlD
Cisapride—HTR3A—blood—hematologic cancer	0.000749	0.0397	CbGeAlD
Cisapride—CYP2C19—hematopoietic system—hematologic cancer	0.000714	0.0379	CbGeAlD
Cisapride—KCNH2—hematopoietic system—hematologic cancer	0.000681	0.0361	CbGeAlD
Cisapride—HTR3A—lung—hematologic cancer	0.000656	0.0348	CbGeAlD
Cisapride—CYP2A6—lung—hematologic cancer	0.000645	0.0342	CbGeAlD
Cisapride—CYP2C8—hematopoietic system—hematologic cancer	0.000623	0.0331	CbGeAlD
Cisapride—CYP1A2—hematopoietic system—hematologic cancer	0.000583	0.0309	CbGeAlD
Cisapride—HTR2B—blood—hematologic cancer	0.000566	0.03	CbGeAlD
Cisapride—CYP3A5—hematopoietic system—hematologic cancer	0.000562	0.0298	CbGeAlD
Cisapride—CYP2B6—hematopoietic system—hematologic cancer	0.000559	0.0297	CbGeAlD
Cisapride—CYP2C9—hematopoietic system—hematologic cancer	0.000554	0.0294	CbGeAlD
Cisapride—HTR2B—lung—hematologic cancer	0.000496	0.0263	CbGeAlD
Cisapride—CYP2C19—blood—hematologic cancer	0.000473	0.0251	CbGeAlD
Cisapride—HTR2A—hematopoietic system—hematologic cancer	0.000456	0.0242	CbGeAlD
Cisapride—KCNH2—blood—hematologic cancer	0.000451	0.0239	CbGeAlD
Cisapride—KCNH2—bone marrow—hematologic cancer	0.000437	0.0232	CbGeAlD
Cisapride—CYP2B6—gonad—hematologic cancer	0.000425	0.0225	CbGeAlD
Cisapride—CYP3A4—hematopoietic system—hematologic cancer	0.000422	0.0224	CbGeAlD
Cisapride—CYP2D6—hematopoietic system—hematologic cancer	0.000415	0.022	CbGeAlD
Cisapride—CYP2C8—blood—hematologic cancer	0.000413	0.0219	CbGeAlD
Cisapride—DRD2—lung—hematologic cancer	0.000401	0.0213	CbGeAlD
Cisapride—CYP1A2—blood—hematologic cancer	0.000386	0.0205	CbGeAlD
Cisapride—DRD2—testis—hematologic cancer	0.000379	0.0201	CbGeAlD
Cisapride—KCNH2—testis—hematologic cancer	0.000373	0.0198	CbGeAlD
Cisapride—CYP3A5—blood—hematologic cancer	0.000373	0.0198	CbGeAlD
Cisapride—CYP2B6—blood—hematologic cancer	0.00037	0.0196	CbGeAlD
Cisapride—CYP2C9—blood—hematologic cancer	0.000367	0.0195	CbGeAlD
Cisapride—HTR2A—gonad—hematologic cancer	0.000347	0.0184	CbGeAlD
Cisapride—CYP2C8—testis—hematologic cancer	0.000341	0.0181	CbGeAlD
Cisapride—HTR2B—lymph node—hematologic cancer	0.000339	0.018	CbGeAlD
Cisapride—CYP1A2—lung—hematologic cancer	0.000339	0.018	CbGeAlD
Cisapride—CYP3A5—lung—hematologic cancer	0.000327	0.0173	CbGeAlD
Cisapride—CYP2B6—lung—hematologic cancer	0.000325	0.0172	CbGeAlD
Cisapride—CYP2B6—testis—hematologic cancer	0.000306	0.0162	CbGeAlD
Cisapride—HTR2A—blood—hematologic cancer	0.000302	0.016	CbGeAlD
Cisapride—CYP3A4—blood—hematologic cancer	0.00028	0.0148	CbGeAlD
Cisapride—CYP2D6—blood—hematologic cancer	0.000275	0.0146	CbGeAlD
Cisapride—KCNH2—lymph node—hematologic cancer	0.000271	0.0144	CbGeAlD
Cisapride—HTR2A—lung—hematologic cancer	0.000265	0.014	CbGeAlD
Cisapride—HTR2A—testis—hematologic cancer	0.00025	0.0133	CbGeAlD
Cisapride—CYP2D6—testis—hematologic cancer	0.000228	0.0121	CbGeAlD
Cisapride—Gefitinib—ABCG2—hematologic cancer	9.55e-05	0.54	CrCbGaD
Cisapride—Gefitinib—ALB—hematologic cancer	4.17e-05	0.235	CrCbGaD
Cisapride—Gefitinib—ABCB1—hematologic cancer	3.98e-05	0.225	CrCbGaD
Cisapride—CYP2A6—Metabolism—PIK3CB—hematologic cancer	3.76e-06	3.65e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CREB1—hematologic cancer	3.75e-06	3.65e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—SDC1—hematologic cancer	3.71e-06	3.61e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	3.71e-06	3.61e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3R1—hematologic cancer	3.71e-06	3.6e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—BRAF—hematologic cancer	3.7e-06	3.6e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.7e-06	3.6e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.7e-06	3.6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CREB1—hematologic cancer	3.69e-06	3.59e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CDKN1A—hematologic cancer	3.67e-06	3.57e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.67e-06	3.57e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.67e-06	3.57e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCL2—hematologic cancer	3.67e-06	3.57e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CREBBP—hematologic cancer	3.67e-06	3.56e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PTEN—hematologic cancer	3.66e-06	3.56e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6R—hematologic cancer	3.66e-06	3.56e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CREBBP—hematologic cancer	3.65e-06	3.55e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—BRAF—hematologic cancer	3.64e-06	3.54e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCL2—hematologic cancer	3.61e-06	3.51e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—JAK2—hematologic cancer	3.6e-06	3.5e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6R—hematologic cancer	3.6e-06	3.5e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	3.59e-06	3.49e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK8—hematologic cancer	3.58e-06	3.48e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.58e-06	3.48e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—hematologic cancer	3.57e-06	3.47e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.56e-06	3.46e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTEN—hematologic cancer	3.54e-06	3.44e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—hematologic cancer	3.53e-06	3.43e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MDM2—hematologic cancer	3.52e-06	3.42e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.51e-06	3.41e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EP300—hematologic cancer	3.49e-06	3.4e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	3.49e-06	3.39e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CD—hematologic cancer	3.48e-06	3.38e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	3.46e-06	3.37e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.46e-06	3.36e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—ALB—hematologic cancer	3.43e-06	3.34e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.43e-06	3.33e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	3.43e-06	3.33e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MTOR—hematologic cancer	3.42e-06	3.32e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CB—hematologic cancer	3.42e-06	3.32e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.41e-06	3.32e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	3.41e-06	3.31e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.4e-06	3.3e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—SRC—hematologic cancer	3.4e-06	3.3e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—KRAS—hematologic cancer	3.39e-06	3.3e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—EP300—hematologic cancer	3.38e-06	3.28e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	3.38e-06	3.28e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—ALB—hematologic cancer	3.35e-06	3.26e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.35e-06	3.25e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	3.34e-06	3.24e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—FGF2—hematologic cancer	3.32e-06	3.22e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—hematologic cancer	3.31e-06	3.22e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.3e-06	3.21e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3R1—hematologic cancer	3.28e-06	3.19e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STAT3—hematologic cancer	3.28e-06	3.18e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.27e-06	3.18e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	3.27e-06	3.18e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NRAS—hematologic cancer	3.27e-06	3.18e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRAS—hematologic cancer	3.27e-06	3.17e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—FGF2—hematologic cancer	3.26e-06	3.17e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—hematologic cancer	3.25e-06	3.15e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.24e-06	3.15e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.23e-06	3.14e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	3.22e-06	3.13e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1B—hematologic cancer	3.21e-06	3.12e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.21e-06	3.12e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—JAK2—hematologic cancer	3.18e-06	3.09e-05	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—hematologic cancer	3.18e-06	3.09e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CD44—hematologic cancer	3.16e-06	3.07e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NQO1—hematologic cancer	3.16e-06	3.07e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CASP3—hematologic cancer	3.15e-06	3.06e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL2—hematologic cancer	3.14e-06	3.05e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.14e-06	3.05e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.14e-06	3.05e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.13e-06	3.05e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	3.13e-06	3.04e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—JAK2—hematologic cancer	3.13e-06	3.04e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL6—hematologic cancer	3.13e-06	3.04e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	3.12e-06	3.03e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.1e-06	3.02e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MDM2—hematologic cancer	3.1e-06	3.02e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—EP300—hematologic cancer	3.1e-06	3.01e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	3.07e-06	2.98e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—hematologic cancer	3.06e-06	2.98e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—JUN—hematologic cancer	3.06e-06	2.97e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MDM2—hematologic cancer	3.05e-06	2.97e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MYC—hematologic cancer	3.05e-06	2.96e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	3.04e-06	2.95e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CB—hematologic cancer	3.03e-06	2.95e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MTOR—hematologic cancer	3.02e-06	2.93e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	3.02e-06	2.93e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.99e-06	2.9e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYCS—hematologic cancer	2.99e-06	2.9e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	2.97e-06	2.89e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MTOR—hematologic cancer	2.97e-06	2.89e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.97e-06	2.89e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CDKN1A—hematologic cancer	2.96e-06	2.88e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.96e-06	2.88e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—hematologic cancer	2.96e-06	2.87e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.94e-06	2.86e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—ALB—hematologic cancer	2.91e-06	2.82e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK8—hematologic cancer	2.89e-06	2.81e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—hematologic cancer	2.88e-06	2.8e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRAS—hematologic cancer	2.88e-06	2.8e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.86e-06	2.78e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	2.84e-06	2.76e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	2.83e-06	2.75e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EP300—hematologic cancer	2.82e-06	2.74e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—KRAS—hematologic cancer	2.81e-06	2.73e-05	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	2.8e-06	2.72e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	2.79e-06	2.71e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.78e-06	2.7e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CASP3—hematologic cancer	2.78e-06	2.7e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL2—hematologic cancer	2.77e-06	2.69e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.77e-06	2.69e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.77e-06	2.69e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL6—hematologic cancer	2.76e-06	2.68e-05	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	2.76e-06	2.68e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.75e-06	2.67e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—SRC—hematologic cancer	2.74e-06	2.66e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CASP3—hematologic cancer	2.73e-06	2.66e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL2—hematologic cancer	2.73e-06	2.65e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.73e-06	2.65e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL6—hematologic cancer	2.71e-06	2.64e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—hematologic cancer	2.7e-06	2.63e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—JUN—hematologic cancer	2.7e-06	2.62e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	2.67e-06	2.6e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—hematologic cancer	2.66e-06	2.58e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—JUN—hematologic cancer	2.65e-06	2.58e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT3—hematologic cancer	2.64e-06	2.57e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NRAS—hematologic cancer	2.64e-06	2.56e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.63e-06	2.56e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.63e-06	2.55e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—hematologic cancer	2.62e-06	2.54e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	2.61e-06	2.54e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—hematologic cancer	2.61e-06	2.54e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—ALB—hematologic cancer	2.59e-06	2.52e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	2.59e-06	2.51e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	2.57e-06	2.5e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—hematologic cancer	2.57e-06	2.49e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.57e-06	2.49e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—hematologic cancer	2.56e-06	2.49e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK8—hematologic cancer	2.55e-06	2.48e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.55e-06	2.48e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—hematologic cancer	2.55e-06	2.47e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.53e-06	2.46e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	2.53e-06	2.45e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.51e-06	2.44e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.5e-06	2.43e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—hematologic cancer	2.5e-06	2.43e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.5e-06	2.43e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—EP300—hematologic cancer	2.5e-06	2.43e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.49e-06	2.42e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EP300—hematologic cancer	2.49e-06	2.42e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.48e-06	2.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.46e-06	2.39e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.45e-06	2.38e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.45e-06	2.38e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.44e-06	2.37e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—EP300—hematologic cancer	2.44e-06	2.37e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.42e-06	2.35e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.42e-06	2.35e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—SRC—hematologic cancer	2.42e-06	2.35e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.42e-06	2.35e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.4e-06	2.33e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRAS—hematologic cancer	2.39e-06	2.32e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—ALB—hematologic cancer	2.39e-06	2.32e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.38e-06	2.31e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—ALB—hematologic cancer	2.36e-06	2.3e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—hematologic cancer	2.36e-06	2.29e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT3—hematologic cancer	2.33e-06	2.27e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.33e-06	2.26e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NRAS—hematologic cancer	2.33e-06	2.26e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.32e-06	2.25e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.3e-06	2.23e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.29e-06	2.23e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.29e-06	2.23e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—hematologic cancer	2.29e-06	2.23e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL6—hematologic cancer	2.29e-06	2.22e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.28e-06	2.22e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—KRAS—hematologic cancer	2.27e-06	2.21e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.26e-06	2.2e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.23e-06	2.17e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—hematologic cancer	2.22e-06	2.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.19e-06	2.13e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MYC—hematologic cancer	2.17e-06	2.11e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TGFB1—hematologic cancer	2.16e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.16e-06	2.1e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.14e-06	2.08e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MYC—hematologic cancer	2.13e-06	2.07e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	2.13e-06	2.07e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—EP300—hematologic cancer	2.11e-06	2.05e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—hematologic cancer	2.11e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.11e-06	2.05e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.09e-06	2.03e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	2.09e-06	2.03e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.05e-06	1.99e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—hematologic cancer	2.04e-06	1.98e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—ALB—hematologic cancer	2.02e-06	1.96e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—hematologic cancer	2.02e-06	1.96e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—KRAS—hematologic cancer	2e-06	1.95e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—hematologic cancer	1.98e-06	1.92e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.97e-06	1.92e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.93e-06	1.88e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.93e-06	1.88e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—EP300—hematologic cancer	1.89e-06	1.83e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—hematologic cancer	1.87e-06	1.82e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.85e-06	1.8e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.85e-06	1.79e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.84e-06	1.79e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—hematologic cancer	1.82e-06	1.77e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.81e-06	1.76e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.81e-06	1.75e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—hematologic cancer	1.8e-06	1.75e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.8e-06	1.75e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.78e-06	1.73e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—hematologic cancer	1.78e-06	1.73e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.75e-06	1.7e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—EP300—hematologic cancer	1.74e-06	1.69e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—EP300—hematologic cancer	1.72e-06	1.67e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.7e-06	1.66e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.7e-06	1.65e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.68e-06	1.63e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.67e-06	1.62e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL6—hematologic cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.6e-06	1.56e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.58e-06	1.54e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—ALB—hematologic cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—hematologic cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—hematologic cancer	1.51e-06	1.47e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.5e-06	1.46e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.49e-06	1.45e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—hematologic cancer	1.48e-06	1.43e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—EP300—hematologic cancer	1.47e-06	1.43e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—hematologic cancer	1.28e-06	1.24e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.24e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—hematologic cancer	1.19e-06	1.16e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—hematologic cancer	1.14e-06	1.11e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—EP300—hematologic cancer	1.13e-06	1.1e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.09e-06	1.06e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—hematologic cancer	1.05e-06	1.02e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—hematologic cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—hematologic cancer	8.89e-07	8.64e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.39e-07	8.16e-06	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—hematologic cancer	6.86e-07	6.66e-06	CbGpPWpGaD
